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Abstract
Recent studies in dairy cows have demonstrated that
serotonergic ligands affect milk yield and composition.
Correspondingly, serotonin (5-HT) has been demonstrated
to be an important local regulator of lactational homeostasis
and involution in mouse and human mammary cells.
We determined the mRNA expression of bovine 5-HT
receptor (HTR) subtypes in bovine mammary tissue (BMT)
and used pharmacological agents to evaluate functional
activities of 5-HT receptors. The mRNAs for ﬁve receptor
isoforms (HTR1B, 2A, 2B, 4, and 7) were identiﬁed by
conventional real-time (RT)-PCR, RT quantitative PCR,
and in situ hybridization in BMT. In addition to luminal
mammary epithelial cell expression, HTR4 was expressed in
myoepithelium, and HTR1B, 2A, and 2B were expressed
in small mammary blood vessels. Serotonin suppressed milk
protein mRNA expression (a-lactalbumin and b-casein
mRNA) in lactogen-treated primary bovine mammary
epithelial cell (BMEC) cultures. To probe the functional
activities of individual receptors, caspase-3 activity and
expression of a-lactalbumin and b-casein were measured.
Both SB22489 (1B antagonist) and ritanserin (2A antagonist)
increased caspase-3 activity. Expression of a-lactalbumin and
b-casein mRNA levels in BMEC were stimulated by low
concentrations of SB224289, ritanserin, or pimozide. These
results demonstrate that there are multiple 5-HT receptor
isoforms in the bovine mammary gland, and point to
profound differences between serotonergic systems of the
bovine mammary gland and the human and mouse mammary
glands. Whereas human and mouse mammary epithelial cells
express predominately the protein for the 5-HT7 receptor,
cow mammary epithelium expresses multiple receptors that
have overlapping, but not identical, functional activities.
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Introduction
Milk secretion is regulated by both systemic and local
feedback mechanisms. Suckling-induced prolactin (PRL)
surges comprise the major positive feedback that drives
elevated milk secretion in response to increased nursing
demand in most species (Wilde et al. 1995). Local negative
feedback processes are initiated by poorly understood
mechanisms that monitor the state of ﬁlling within each
gland. These mechanisms regulate alveolar distension, milk
synthesis and secretion, and epithelial cell mass (Peaker 1995).
Acting in concert, systemic and local hormonal factors adjust
mammary gland physiology not only to meet the demands of
the offspring, butalso to compensate forcircumstances such as
local mastitis, nutrient supply, and metabolic demand.
Even in the face of continued endocrine stimulation,
mammary glands that are unsuckled will halt milk synthesis
and undergo partial involution, resulting in loss of epithelial
cell mass (Peaker 1995). In many species, including rodents
and humans, involution is characterized by massive apoptosis.
In other species, including dairy cattle, the glands become
quiescent during involution, but do not undergo apoptosis
and remodeling on a large scale (Capuco & Akers 1999).
Consequences of milk stasis have been known for many years,
butmechanisms responsiblefor stasis-induced involution have
remained obscure. One line of research that explored this
issue proposed the presence of a ‘feedback inhibitor of
lactation’ compound in milk whose identityand physiological
activity have not been conﬁrmed. This factor was proposed to
decrease milk yield, milk protein synthesis, and milk protein
mRNA expression, both in vivo and in vitro and in a variety of
species (Wilde et al. 1988).
Serotonin (5-HT) has been proposed to be an autocrine/
paracrine regulator of lactation in the mouse, human, and
more recently in the bovine, and the enzymatic machinery
necessary for 5-HT biosynthesis has been detected in the
mammary epithelium (Matsuda et al. 2004, Stull et al. 2007,
Hernandez 2008, Hernandez et al. 2008, Pai & Horseman
2008). Expression of tryptophan hydroxylase 1 (TPH1) in
mammary epithelial cells, the rate-limiting enzyme in 5-HT
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cultures, and by milk stasis in nursing dams (Matsuda et al.
2004). Serotonin content was measured in the mammary
gland of virgin, lactating, and 5-hydroxtryptophan-treated
mice. Serotonin content of the mammary gland was increased
in lactating mice compared with virgin and, when treated
with 5-hydroxytryptophan, 5-HT levels in the mammary
gland were further increased (Stull et al. 2007). In cultures
of primary mouse mammary epithelial cells, expression of
b-casein mRNA was attenuated by increasing concentrations
of 5-HT. Furthermore, when methysergide (METH), a non-
selective 5-HT antagonist, was added to cultures, expression
of b-casein mRNAwas increased (Matsuda et al. 2004). Non-
transformed human mammary epithelial cells (MCF10A)
were demonstrated to express mRNA for the human 5-HT7
receptor (HTR7) on basolateral membranes, and 5-HT
reuptake transporter (SERT) on the apical membrane (Stull
et al. 2007). Additionally, it was determined that 5-HT was
involved in the regulation of tight junction (TJ) status in the
MCF10A cells. Addition of METH or metergoline, both
broad-spectrum 5-HT receptor antagonists, resulted in
increases in transepithelial resistance (Stull et al. 2007). The
TJ scaffolding proteins, ZO-1 and ZO-2, were also decreased
in 5-HT-treated MCF10A cells.
Studies in three-dimensional collagen cultures of bovine
mammary epithelial cell (BMEC) have shown TPH1 to be
expressed in a PRL-dependent manner (Stiening 2005,
Hernandez et al. 2008). Furthermore, BMEC treated with
5-HT had decreased milk protein gene expression, and
treatment with METH or parachlorophenylalanine (TPH1
enzyme inhibitor) increased milk protein gene expression
(Hernandez et al. 2008). To date, no information is present on
the identity of 5-HT receptors in bovine mammary tissue
(BMT). Therefore, the objectives of these studies were to
determine 1) which 5-HT receptor(s) are present in the
bovine mammary gland and BMEC, 2) which selective
antagonists for 5-HT receptors affect b-casein and
a-lactalbumin mRNA expression in BMEC, and 3) deter-
mine whether 5-HTand selective 5-HTreceptor antagonists
affect caspase-3 activity in cultures of BMEC. The results of
these studies point to profound functional activities of 5-HT
in the bovine mammary epithelium and substantial complex-
ity in the bovine 5-HT system, which has not yet been
reported in the human or mouse 5-HT systems.
Materials and Methods
Expression of HTR subtypes in bovine brain, mammary tissue,
and mammary epithelial cells
The characterization of expression for serotonergic com-
ponents was initially performed on a pool of isolated bovine
mammary cells representing four multiparous, non-lactating,
pregnant cows. The expression patterns for 5-HTreceptors in
the pooled sample were conﬁrmed in assays of four pBMEC
isolatesfromindividualcows.Additionally,expressionpatterns
for 5-HT receptors were determined on a bovine mammary
epithelial cell line (BME–UV). The morphological distri-
bution of receptors was documented using bovine mammary
and hypothalamic tissues from an individual lactating cow.
Mammary epithelial cells were collected from four multi-
parous, non-lactating (w30 days dry), pregnant Holstein
cows. Holstein hypothalamic (BB) and BMTwere collected
at slaughter from a multiparous lactating cow in the ﬁrst
trimester of pregnancy, and ﬁxed at 4 8C in 4% paraformalde-
hyde (PFA) for 14–24 h. The tissues were submerged in
30% sucrose at 4 8C overnight, then submerged in a 1:1 v:v
30%sucrose:OCT(TissueTek,SakuraFinetek,Torrance,CA,
USA) mixture for 24 h at 4 8C. Tissues were embedded with
OCT (Tissue Tek) and frozen at K80 8C. Eight micron tissue
sections were then cut with a cryostat (Microm HM 520).
Other portions of BB and BMT were used for RNA
isolation and snap frozen in liquid nitrogen. Tissue was stored
at K80 8C until RNA extraction.
Total RNA was isolated from BB, BMT, BMEC, and
BME–UV samples using TRIzol reagent (Invitrogen) in
triplicate. For primaryepithelial cell culture experiments, two
wells of a 24-well culture plate served as one sample and there
were four samples for each treatment. In a given experiment,
each treatment was represented in each culture plate, resulting
in four culture plates per study. Samples were stored at
K80 8C until extraction. Extraction was conducted as
described previously (Hernandez et al. 2008).
Quantitative real-time (RT)-PCR analysis was conducted
using the iCycler IQ RT-PCR Detection System (Bio-Rad).
Hypoxanthine phosphoribosyltransferase I (HPRT1)w a s
utilized as the internal control gene following standard
curve analysis across all treatment group samples. Several
other housekeeping genes were evaluated (ribosomal protein
S18, glyceraldehyde 3 phosphate, and b-actin) and HPRT1
did not alter its expression based ontreatment.Resulting gene
expression data were calculated and analyzed based on the
2KDDCt method (Livak & Schmittgen 2001). Ampliﬁcation
efﬁciencies of primers were evaluated prior to conducting
experiment to determine equality of internal control
compared with primers. All primers utilized met criteria for
analysis by the 2KDDCt method, with efﬁciencies between 95
and 105% (Livak & Schmittgen 2001). Amplicons were
sequenced from RT-PCR products prior to the use of
primers for quantitative PCR (qPCR). Primer sequences are
shown in Table 1.
BMT was counterstained after in situ hybridization for
smooth muscle a-actin (SMA) to identify myoepithelial cells
and for Griffonia simplicifolia lectin I isolectin B4 (GS-I) to
identify vasculature in BMT. Primary biotinylated antibody
was obtained (#B-1205; Vector Laboratories, Burlingame,
CA, USA) for biotinylated GS-I. Primary antibody for SMA
(#MS-113-P0; Thermo Scientiﬁc, Fremont, CA, USA) was
visualized with a biotinylated goat anti-rabbit secondary
antibody (#170-6401; Bio-Rad Laboratories) for immuno-
histochemical detection in BB and BMT following in situ
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Kit (Vector Laboratories) was used for staining following the
manufacturer’s instructions, and the following primary
antibody dilutions were utilized: 3 mg/ml GS-I; 1:800 SMA.
Proteins were visualized using DAB peroxidase substrate per
manufacturer’s instructions (Vector Laboratories).
In situ hybridization for HTR in BMT
HTR1B, 2A, 2B, 4, and 7 cDNA clones were generated by
PCR ampliﬁcation from total RNA extracted from BB.
Primers for speciﬁc genes of interest were designed against
bovine sequences for HTR1B, 2A, 2B, and 4 receptors as
reported in National Center for Biotechnology Information
(NCBI; Bethesda, MA, USA). The HTR7 receptor was
designed using human sequences for the receptor and
compared with bovine genome (NCBI). The HTR7 receptor
primer was generated from primer 3 (Rozen & Skaletsky
2000). The following primer sequences were used for probe
generation: HTR1B were 50-ATGGAGAAGACCCACAC-
CAG and GTGATTGCCACTGTGTACCG-30; HTR2A
were 50-TTCTCCCTGACTCCTCAAAACTG and GGC-
ATTCTGCAGCTTTTTCTCTA-30;HTR2Bwere50-CGA-
TTCTGCCACAACAAGAA and TTCCCTGTTCCTCA-
CCAGTC-30; HTR4 were 50-CTCTGGATGTCCTGCT-
CACA and CATGCGATGAGTGCTATGCT-30;a n dHTR7
were 50-CTTTGGCCATTTCTTCTGTAACG and TGGA-
GATGTTTTTCCTTTCGTGT-30.A m p l i ﬁ e dD N A
products for 5-HT receptors were inserted into the TOPO
TA cloning expression vector pCRII (Invitrogen) and
chemically transformed into Mach1-T1 Escherichia coli
(Limesand et al. 2005). Plasmids positive for PCR inserts
were transformed and plasmid DNA was isolated (Qiagen)
and sequenced. Chromas and BLAST (NIH) were used to
analyze DNA sequences generated from PCR and conﬁrm
sequence identity.
RNA probes were synthesized using plasmid DNA that
was linearized using endonuclease restriction enzymes and
extracted. Digoxigenin (DIG)-labeled RNA probes (Roche
Diagnostics) were generated with SP6 or T7 RNA
polymerase (Promega), precipitated with 70% ETOH, and
resuspended. Probe absorbance was measured with a
NanoDrop Spectrophotometer ND-1000 to determine
concentration and integrity.
Insitu hybridizationwas conducted on frozen sections ﬁxed
in 4% PFA for 10 min, washed in 1!PBS, digested with
10 mg/ml proteinase K for 10 min, and reﬁxed in 4% PFA for
5 min. Tissues were washed in PBS and then acetylated
(102.2 mM triethanolamine, 0.01 mM 6 M HCl, and
26.9 mM acetic anhydride) for 10 min at room temperature,
washed in PBS, and then blocked with 55 8Cp r e -
hybridization buffer (50% formamide, 5!sodium chloride/
sodium citrate (SSC), pH 4.5, 50 mg/ml yeast tRNA, 1%
SDS, and 50 mg/ml heparin) for 2 h at 55 8C in a humidiﬁed
chamber. The DIG-labeled RNA for sense (negative control)
and anti-sense strands for each receptor was then separately
addedtohybridizationbuffer(HTR1B:anti-sense66.80 ng/ml,
sense 92.01 ng/ml; HTR2A: anti-sense 19.5 ng/ml, sense
103.1 ng/ml; HTR2B: anti-sense 84.59 ng/ml, sense
150.40 ng/ml; HTR4: anti-sense 56.15 ng/ml, sense 78.40 ng/ml;
HTR7:anti-sense68.30 ng/ml,sense63.09 ng/ml),heatdenatured
at 80 8C for 5 min, cooled, then hybridization buffer with DIG-
RNA for sense and anti-sense strands for each receptor was added
to separate slides on tissue sections and incubated overnight at
70 8C in a humidiﬁed chamber. Sections were washed in 70 8C
5!SSC, pH 7.0, for 30 min at room temperature, incubated in
0.2!SSC, pH 7.0, for 3 h at 75 8C, then washed at room
temperature in 0.2!SSC for 5 min. Tissues were subsequently
washed in 1!malic acid buffer (MAB), pH 8.0, then incubated in
blocking buffer consisting of 2% blocking reagent in MAB
(Roche Diagnostics), 10% heat inactivated FBS (Gibco), 0.1%
Tween-20 for 1 h at room temperature. Anti-DIG-AP Fab
Table 1 Primers utilized for RT-PCR and qPCR analyses. All 5-HTreceptors were run at an annealing temperature of 64 8C. Primers for 5-HT
receptors 1A–4 were obtained from Reist et al. (2003) and speciﬁc to the bovine genome. The 5-HT7 was designed using primer 3 (Rozen &
Skaletsky2000)andthesequencewasobtainedfromGenBank(NIH,Bethesda, MD, USA),accessionnumberXM_580794.HPRT1was used
as the housekeeping gene and was also run at an annealing temperature of 64 8C. b-Casein was run at a 64 8C annealing temperature and
a-lactalbumin was run at a 62 8C annealing temperature
Forward primer (50 to 30) Reverse primer (50 to 30)
Primer
HTR1A TCAGCTACCAAGTGATCACCTCT GTCCACTTGTTGAGCACCTG
HTR1B TGCTCCTCATCGCCCTCTATG CTAGCGGCCATGAGTTTCTTCTT
HTR1D CCTCCAACAGATCCCTGAATG CAGAGCAATGACACAGAGATGCA
HTR1F TGTGAGAGAGAGCTGGATTATGG TAGTTCCTTGGTGCCTCCAGAA
HTR2A AGCTGCAGAATGCCACCAACTAT GGTATTGGCATGGATATACCTAC
HTR2B AAACAAGCCACCTCAACGCCT TCCCGAAATGTCTTATTGAAGAG
HTR2C TTCTTAATGTCCCTAGCCATTGC GCAATCTTCATGATGGCCTTAGT
HTR4 ATGGACAAACTTGATGCTAATGTGA TCACCAGCACCGAAACCAGCA
HTR5a ACAACGGGGACATCTAGGG TTGGGACATGGTAAGTACTAGGG
HTR7 GTTTTATATCCCCATGTCCGTCA TTTGCACACTCCTCTACCTCCT
b-Casein GCTATGGCTCCTAAGCACAAAGA GGAAACATGACAGTTGGAGGAAG
a-Lactalbumin CTCTGCTCCTGGTAGGCATC ACAGACCCATTCAGGCAAAC
HPRT1 GAGAAGTCCGAGTTGAGTTTGGAA GGCTCGTAGTGCAAATGAAGAGT
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blocking buffer and incubated at 4 8C overnight in the dark.
Following incubation, BB and BMT sections were washed in
MAB with 0.1% Tween-20, then in DI water with 0.1% Tween-
20 and then developed with BM Purple AP Substrate (Roche
Diagnostics) containing 0.1% Tween-20 for 3–36 h until
maximum intensity was achieved.
Effects of serotonergic drugs on primary BMECs in collagen gel
cultures
Tissue dissociation, BMEC isolation, and preparation of
type 1 collagen were performed according to (McGrath 1987,
Hernandez et al. 2008, Stiening et al. 2008). Epithelial cells in
the form of organoids clumps composed of ductal and alveolar
cells were isolated from four multiparous, non-lactating
(w30 days dry), pregnant Holstein cows. Organoids were
thawed, resuspended in DMEM/F-12, mixed with neutral-
ized collagen at 4–6!10
5 organoids/ml of collagen mixture,
and cultured in 24-well plates as described previously
(Hernandez et al. 2008, Stiening et al. 2008). The average
DNA content of one vial of BMEC is 486.7G84.91 mg/ml
(meanGS.D). This provided sufﬁcient cells for 72 wells or
w6.8 mg DNA/well.
Mammary cell organoids were allowed to grow for 8 days
in serum-free media (100 ng/ml insulin-like growth factor-I
(IGFI) and 25 ng/ml epidermal growth factor (EGF)), and
then treated with a lactogenic hormone complex (100 ng/ml
IGFI, 100 ng/ml PRL, and 10 ng/ml hydrocortisone, with-
out EGF) plus gel release from the plastic by rimming of the
gels from the plastic, simultaneously, for 48 h in combination
with and without 5-HT receptor antagonists, as previously
described (Hernandez et al. 2008). The lactogenic hormone
complex in serum-free media served as the control, and 5-HT
antagonists in combination with the lactogenic complex
served as treatments, with the entire experiment being
replicated an additional time. At termination of lactogenic
treatments, gels were dissolved in 1 ml TRIzol for 5 min
(Invitrogen) and stored at K80 8C until RNA extraction.
Two gels were utilized per replicate and four replicates per
treatment were completed. For caspase activity assays,
collagen gels were digested with 0.1% collagenase I
(collagenase type 1, Worthington Biochemical Corp.,
Lakewood, NJ, USA) in Hank’s balanced salt solution with
4% BSAfor 20 min at 37 8C(Rochaet al. 1985). Thismixture
was centrifuged for 4 min at 100 g and supernatant removed.
Cells were washed with M199, centrifuged for 4 min at
100 g, and supernatant removed. Cell pellets were stored at
K80 8C until caspase-3 activity assay was conducted. Two
wells of a 24-well plate served as an NZ1, and an NZ4w a s
completed (eight total gels) for each treatment group for the
two experimental replicates.
The effects of 5-HT (Sigma; 200 mM) and selective 5-HT
receptor antagonists/reverse agonists for the 1B (SB224289;
Sigma), 2A (ritanserin; Sigma), 2B (SB204741; Sigma), four
(SB204070; Sigma), and seven (pimozide; Sigma) receptors
were investigated during the lactogenic period of culture
(48 h) in combination with lactogenic hormones. A 200 mM
concentration of 5-HTwas utilized as this was determined to
be an effective concentration in other mammaryepithelial cell
models (Matsuda et al. 2004, Hernandez et al. 2008, Pai &
Horseman 2008). Concentrations of 5-HTreceptor antagon-
ists ranged from 0.5t o1 0mM, except for SB204070, which
ranged from 0.0001 to 1.0 mM. Cultures treated with
lactogenic media only, plus gel release served as the control.
Effects of speciﬁc 5-HTreceptor antagonists/reverse agonists
onexpressionofmRNAfor milkproteingenesa-lactalbumin
and b-casein during lactogenesis were also investigated.
For caspase-3 activity measurements, the following
concentrations of 5-HT and 5-HT receptor antagonists
were utilized during lactogenic treatment: 200 mM 5-HT
(Sigma), 0.1 mM pimozide, 1.0 mM ritanserin, 0.0001 mM
SB204070, 0.1 mM SB204741, and 1.0 mM SB224289.
Cultures treated with lactogenic media only, plus gel release
served as the control. At termination of lactogenic treatments,
gels were harvested and treated for protein isolation for
caspase-3 activity and stored at K80 8C.
Activation of caspase-3 was quantiﬁed using BioMol
QuantiZyme Colormetric Assay kit (BioMol, Plymouth
Meeting, PA, USA), measuring the rate of Ac-DEVD-pNA
cleavage. Caspase-3 is a committed step for caspase activity in
cells that undergo apoptosis. Methods utilized were based
upon (Limesand et al. 2003).
Statistical analysis and 5-HT nomenclature
Statistical analysis was conducted using a one-way ANOVA
on qPCR data using gene expression relative to the control
(lactogenic mediaCgel release) in a respective sample, with
the PROC MIXED procedure of SAS (SAS, 9.3, SAS
Institute, Cary, NC, USA). Graphical representation of data is
represented by expression of treatments relative to the control
(2KDDCt). The DDCt was calculated as DCt of a respective
treatment minus DCt of the control. A one-way ANOVAwas
conducted on results from caspase-3 activity assay, with the
PROC MIXED procedure of SAS (SAS, 9.3, SAS Institute).
Nomenclature utilized for the mRNA 5-HT receptors
(HTR humans/HTR non-human species) was derived from
the NCBI. Nomenclature utilized for the protein form of the
5-HTreceptors (5-HTR) was derived from the International
Union of Basic and Clinical Pharmacology (www.iuphar.org,
IUPHAR, Kansas City, KS, USA).
Results
Expression of 5-HTreceptors in the bovine mammary gland
Serotonin exerts its cellular actions through multiple receptor
subtypes belonging to seven different families. Determination
of 5-HTreceptor subtypes present in BMEC and BMTwas a
necessary ﬁrst step for establishing the basis of 5-HTactions in
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BMEC expresses TPH-1, the rate-limiting enzyme for 5-HT
biosynthesis and the serotonin re-uptake transporter, necess-
ary for 5-HT recycling into the cell (Hernandez 2008,
Hernandez et al. 2008). To validate detection of receptor
subtypes by RT-PCR, BB served as a control because all
5-HTreceptors are present in brain tissue (Kroeze et al. 2002).
Receptor types that were validated by amplifying BB cDNA
included HTR1A, 1B, 1D, 1F, 2A, 2B, 2C, 4, 5A, and 7
(Fig. 1 and data not shown). These primers were used for
detecting mRNA expression in BMT. Other receptors that
were not included in these assays (e.g. types 3, 6, and a variety
of subtypes) may be expressed, but further validation studies
would be necessary to develop adequate assays.
Expression of genes encoding the proteins for 5-HT1B, 2A,
2B, 4, 7 receptors was detected in BMT and BMEC (Fig. 1).
The mRNAs for HTR1A, 1D, 1F, 2C, and 5A receptors
were not detected in BMT or BMEC (data not shown).
Additionally, expression of genes encoding the proteins for
5-HT1B, 2A, 2B, 4, 7 receptors was detected in a BME–UV
(data not shown). Additionally, mRNA for HTR1D was
detected in BME–UV cells (data not shown).
Relative expression levels for each receptor of the ﬁve
subtypes that were expressed in BMTwere determined using
qPCR. Levels of each receptor mRNAwere quantiﬁed as the
ratio of BMT expression to the level in BB extracts. The
expression ratio of receptor mRNA relative to BB for each
type in BMT, highest to lowest, was as follows: HTR4, 389;
HTR2B, 89; HTR1B,1 9 .35; HTR7, 18; and HTR2A,3 .8.
In BMEC, the expression ratio relative to BB (highest to
lowest) was: HTR4, 230; HTR2B, 44; HTR7, 37; HTR1B,
30; and HTR2A,1 .6. The rank order of expression ratios was
similar for most of the receptors in both BMT and BMEC,
with the exception of HTR7, which was enriched in BMEC.
The relative enrichment of 5-HT7 in epithelial cells is
consistent with expression of this receptor in the mammary
epithelium in mice and humans (Stull et al. 2007, Pai &
Horseman 2008).
Having determined that genes encoding proteins of several
5-HT receptor subtypes were expressed in BMT, it was
necessary to determine what cell types expressed each.
Therefore, in situ hybridization assays for HTR1B, 2A, 2B,
4 and 7 were conducted. BB was used as a positive control and
sense probes for receptors were used as negative controls
(Fig. 2). Sections for each receptor probe were counterstained
with GS-I or SMA to identify vascular endothelial and
myoepithelial cells respectively (Fig. 2).
Expression of HTR1B, 2A, 2B, 4, and 7 was each localized
in BMT (Fig. 2, row A, columns 1–5). Counterstaining with
GS-I (vascular endothelium) indicated that HTR1B, 2A, and
2B were present in the endothelium in addition to epithelium
(Fig. 2). Myoepithelium expressed HTR4 (Fig. 2).
Agonist effects on milk protein mRNA expression and apoptosis
Serotonin has been demonstrated to decrease milk protein
mRNA expression in primary mouse mammary epithelial
cells and to induce apoptosis human and mouse mammary
epithelial cells (Matsuda et al. 2004, Stull et al. 2007).
Therefore, it was pertinent to determine whether 5-HT
treatment of BMEC would also result in decreased milk
protein mRNA expression and increased apoptosis.
Treatment of lactogenic collagen gel cultures of BMEC
(lactogenic hormones, plus gel release) with exogenous 5-HT
depressed b-casein mRNA expression by O90% compared
with BMEC treated with lactogenic conditions only
(P!0.0001; data not shown). Similarly, 5-HT suppressed
a-lactalbumin mRNA by O80% in comparison with
lactogenic control (P!0.0001; data not shown).
When lactogenic cultures of BMEC were treated with
exogenous 5-HT, there was no signiﬁcant increase in
apoptosis as measured by caspase-3 activity (PZ0.10).
Effects of 5-HTreceptor antagonists on milk protein mRNA
expression and apoptosis in primary BMECs
The effects of selective 5-HT antagonists/inverse agonists
were tested in collagen gel cultures of BMEC under
lactogenic conditions (lactogenic hormone stimulation plus
gel release). For each receptor, an antagonist was chosen
based on its relative selectivity for the target receptor
compared with other receptors that were identiﬁed in
BMEC. Antagonists utilized were as selective for a speciﬁc
5-HT receptor of interest as possible. Concentration-
response curves for each antagonist were performed using
a range of concentrations previously documented to
encompass established IC50 for the target receptor. The
antagonists and their respective receptors included SB224289
Figure 1 5-HT receptor expression in bovine hypothalamic tissue,
lactating mammary tissue, and primary bovine mammary epithelial
cells. The mRNA expression of the HTR was detected by RT-PCR
and electrophoresed through a 2% agarose gel and stained with
EtBR (primers listed in Table 1). Lane (A) Holstein hypothalamic
tissue, Lane (B) lactating Holstein mammary gland tissue from a ﬁrst
trimester pregnant animal, and Lane (C) primary bovine mammary
epithelial cells isolated from three multiparous, non-pregnant
(w30 days dry), Holstein cows treated for 7 days with serum-free
proliferation media (IGF-I, EGF and INS).
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SB204741 (5-HT2B), and pimozide (5-HT7).
In the case of 5-HT1B, SB224289, at 0.5, 1.0, and 2.0 mM,
up-regulated a-lactalbumin mRNA expression 10, 11, and
22-fold respectively (P!0.05; Fig. 3A) relative to lactogenic
control. Exogenous 1.0 and 2.0 mM ritanserin (5-HT2A
receptor antagonist) increased a-lactalbumin mRNA levels
relative to lactogenic control 17 and 11-fold respectively
(P!0.001 respectively; Fig. 3B). Pimozide (5-HT7 receptor
antagonist) at 0.2 mM increased a-lactalbumin mRNA
16-fold compared with lactogenic control (P!0.001;
Fig. 3C). We failed to detect changes in a-lactalbumin
mRNA expression when BMEC was treated with exogenous
antagonists to 5-HT2B and 5-HT4 receptor subtypes (data
not shown).
b-Casein mRNA expression was up-regulated relative to
the lactogenic control when treated with 1.0 and 2.0 mM
SB224289 (P!0.05; Fig. 4A). Additionally, antagonism of
the 5-HT2A,7 receptors with exogenous ritanserin (2.0 mM)
and pimozide (0.1a n d0 .2 mM) signiﬁcantly increased
b-casein mRNA expression (Fig. 4B and C). We were unable
to detect signiﬁcant effects on b-casein mRNA expression
when BMEC was treated with antagonists to 5-HT2B,4
receptor subtypes (data not shown).
Treatment of BMEC with 1.0 mM 5-HT1B and 5-HT2A
receptor antagonists increased caspase-3 activity (P!0.05 and
P!0.001 respectively; Fig. 5). All other 5-HT receptor
antagonists did not affect caspase-3 activity, a marker of
apoptosis (PO0.05; Fig. 5).
Discussion
Recently, the 5-HT7 receptor has been discovered in human
and mouse mammary epithelium (Stull et al. 2007).
Furthermore, it was demonstrated that the mammary gland
epithelial cells contain the enzymatic machinery to produce
Figure 3 Effects of selective 5-HT receptor antagonists on
a-lactalbumin mRNA expression in primary bovine mammary
epithelial cells. Mean with S.E.M. of (A) a-lactalbumin mRNA
expression in lactogenic BMEC cultures treated with SB224289,
a 5-HT-1B receptor antagonist; (B) a-lactalbumin mRNA expression
in lactogenic BMEC cultures treated with ritanserin, a 5-HT-2A
receptor antagonist; and (C) a-lactalbumin mRNA expression in
lactogenic BMEC cultures treated with pimozide, a 5-HT-7 receptor
antagonist. Columns with * indicate statistical signiﬁcance of
*P!0.05, **P!0.001, ***P!0.0001 compared with lactogenic
control.
Figure 2 Morphological distribution of HTR in lactating bovine
mammary tissue. In situ hybridizations of DIG-labeled anti-sense
cRNA probes for HTR1B, HTR2A, HTR2B, HTR4, and HTR7,a s
well as representative anti-sense cRNA DIG-labeled probe in the
mammary gland. Anti-sense cRNA-labeled probe for HTR7 in the
bovine hypothalamus is also provided. A representative section that
has been stained for HTR7 and has been counterstained for smooth
muscle a-actin and GS-I is shown. Black arrows (/) indicate
epithelial cells. Arrowheads (^) represent myoepithelial cells, and
asteriks (*) correspond to vascular endothelium.
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SERT), and that more 5-HT is detectable in the mammary
gland during lactation (Matsuda et al. 2004, Stull et al. 2007,
Hernandez 2008, Hernandez et al. 2008). Additionally,
it was demonstrated that 5-HT disrupts mammary
epithelial TJ, and this occurs through action of 5-HT7
(Pai & Horseman 2008). In cattle, 5-HT has been demons-
trated to reduce milk production in late lactation and to
negatively impact milk protein gene expression in BMEC
cultures (Hernandez et al. 2008).
We tested BB and BMT isolated from a single pregnant,
lactating Holstein cow, and BMEC isolated from four non-
lactating, pregnant Holstein cows, cultured in collagen gels, as
well as a BME-UV, for mRNA for the HTR1A, 1B, 1D, 1F,
2A, 2B, 2C, 4, 5A, and 7. We detected mRNA of all 5-HT
receptors in BB. mRNA for the HTR1B, 2A, 2B, 4, and 7
was detected in both BMTand BMEC by RT-PCR (Fig. 1).
All ﬁve receptors were also localized to the mammary
epithelium by in situ hybridization (Fig. 2), suggesting a very
complex local regulation of the bovine mammary gland by
5-HT. We have previously demonstrated that in vivo intra-
mammary infusions of 5-HT resulted in a 10% decrease in
milkyieldinlate-lactationHolsteincows,andMETHresulted
in a 10% increase in milk yield (Hernandez et al. 2008).
Herein, we report that 5-HT suppressed transcription of
milk protein genes (P!0.0001). Serotonin has also been
reported to increase apoptosis in mouse mammary explant
cultures (Matsuda et al.2 0 0 4 ). In three-dimensional
lactogenic collagen cultures of BMEC treated with 200 mM
5-HT, we saw no signiﬁcant increase in caspase-3 activity
relative to lactogenic controls (PZ0.10). Although contrary
to the extensive apoptosis seen in mice upon treatment with
5-HT, there may be a solid biological basis for this difference.
Dairy cows do not undergo extensive remodeling of BMT to
a virgin-like state during their involution/dry period (Akers
2002). No evidence of a net loss of mammaryepithelial cells is
apparent in lactating versus non-lactating cows. Furthermore,
dairy cows undergo more extensive cell turnover during
lactation than mice or humans (Capuco et al. 1997, 2006).
Figure 4 Effects of selective 5-HT receptor antagonists on b-casein
mRNA expression in primary bovine mammary epithelial cells.
Mean with S.E.M. of (A) b-casein mRNA expression in lactogenic
BMEC cultures treated with SB224289, a 5-HT-1B antagonist;
(B) b-casein mRNA expression in lactogenic BMEC cultures treated
with ritanserin, a 5-HT-2A receptor antagonist; and (C) b-casein
mRNA expression in lactogenic BMEC cultures treated with
pimozide, a 5-HT-7 receptor antagonist. Columns with *Indicate
statistical signiﬁcance of *P!0.05, **P!0.001, ***P!0.0001
compared with lactogenic control.
Figure 5 Caspase-3 activity in primary bovine mammary epithelial
cells treated with 5-HT receptor antagonists. Mean with S.E.M.o f
caspase-3 activity in lactogenic cultures of BMEC treated with
1.0 mM SB224289, 1.0 mM ritanserin, 0.1 mM SB204741,
0.0001 mM SB204070, and 0.1 mM pimozide. Columns with
* indicate statistical signiﬁcance of *P!0.05; ***P!0.0001.
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with 5-HT is not entirely surprising.
We determined that HTR1B mRNA was enriched in
BMEC and in BMT, suggesting that it is predominately found
in BMEC, although it appears to be also expressed in the
vasculature of the mammary gland. We demonstrated that
SB224289 (1B antagonist) up-regulated a-lactalbumin and
b-casein mRNA expression in BMEC exposed to a
lactogenic treatment (Figs 3A and 4A). Increasing cyclic
AMP enhances secretion in mammary epithelial cells, and
potentially 5-HT1B could be blocking this pathway because it
is negatively coupled to cAMP production (Boisgard et al.
2001). In these studies, we demonstrated that treatment of
BMEC with SB224289 increased apoptosis compared with
lactogenic controls (Fig. 5). In the bovine, a considerable
amount of cell renewal occurs, such that by the end of
lactation, the majority of cells present has been produced
during the lactation cycle (Capuco et al. 2001, 2003)
Apoptosis is crucial to turnover of cells in BMT during
lactation (Capuco et al. 2003, Hadsell et al. 2007).
Additionally, it has been suggested that increasing cell
turnover in BMT could aid in increasing secretory capacity
in individual BMEC or could increase replacement of less
functional cells (Capuco et al. 2006).
The 5-HT2A has low afﬁnity for 5-HTand has been shown
to activate phospholipases (A2, C, and D), and therefore
increase intracellular Ca
2C levels, activate Janus kinase/signal
transducers and activators of transcription (Jak/Stat) pathway,
and increase glucose uptake by skeletal muscle by increasing
glucose transporters (GLUT) 1, 3, and 4 in the plasma
membrane (Hadjuch et al. 1999, Raymond et al. 2001, Banes
et al. 2005). Glucose uptake by BMT is a required step in
producing lactose, the primary carbohydrate and major
osmolyte in milk. The major GLUT in the mammary gland
is GLUT1 (Akers 2002). PRL stimulates the Jak/Stat pathway
(Jak2/Stat5) in the mammary gland, which is responsible for
the induction of milk protein expression in BMEC as well as
other mammary epithelial cells due to the presence of Stat5-
binding sites on the epithelial cells, and this could be a
potential regulatory pathway by which 5-HT acts through
5-HT2A (Horseman 1999). Our studies indicate that the
mRNA for the HTR2A is present in BMTand potentially in
cells of the vascular system of BMT (Fig. 2). Expression of
mRNA for this receptor was 3.77-fold in BMT and 1.64 in
BMEC relative to BB. We observed that treatment of BMEC
with ritanserin increased a-lactalbumin and b-casein mRNA
compared with lactogenic controls (Figs 3B and 4B). The
5-HT2A is involved in contraction of vascular smooth muscle
cells through ERK/MAPK pathway (Watts 1998). This
action could be involved in the regulation of blood ﬂow to the
mammary gland, which is important in supporting lactation
(Collier et al. 1984).
We detected the presence of HTR2B mRNA in BMT
(Fig. 2). These receptors are also involved in regulation of
morphogenesis and mitogenesis, and stimulate ERK and cell
cycle components (Raymond et al. 2001). We did not detect
any effects on milk protein gene expression or milk protein
levels when treating lactogenic cultures of BMEC with
SB204741 (2B antagonist). Thus, this receptor may not be
involved in the regulation of milk protein genes in the bovine,
but other processes not measured.
We identiﬁed the HTR4 mRNA in BMT as well as
BMEC, and potentially in the myoepithelium (Fig. 2).
However, no effects were observed on milk protein gene
expression or apoptosis when BMEC was treated with a
5-HT4 receptor antagonist. This may also not be surprising
since we did not measure the milk ejection reﬂex in these
studies.
The 5-HT7 receptor subtype is positively coupled to
adenylyl cyclase through Gs, and has been detected in both
human and mouse mammaryepithelial cells on the basolateral
side of the membrane (Stull et al. 2007). We also detected
HTR7 mRNA in BMTand BMEC (Fig. 2). Additionally, it
has been demonstrated that 5-HT, through cAMP, regulates
TJ status in human mammary epithelial cells in a biphasic
manner, with long-term exposure to 5-HT resulting in a
disruption of TJ status through a p38 MAPK pathway (Pai &
Horseman 2008). We detected an increase in a-lactalbumin
and b-casein mRNA expression when BMEC was treated
with a 5-HT7 antagonist (Figs 3C and 4C). In epithelial cells,
cAMP and protein kinase A have been demonstrated to
stimulate apically directed transcytosis and secretion (Muniz
et al. 1996). Furthermore, it has been demonstrated that an
increase in cAMP results in increased casein secretion in
mammary epithelial cells through protein kinase A (Boisgard
et al. 2001).
Serotonin receptor activation patterns in vivo are unknown,
and could effect milk protein gene expression variably.
In addition to tissue-autonomous mechanisms explored to
date, some mechanisms of 5-HT action may involve extra-
epithelial actions. For instance, 5-HT acts as a mammary
artery vasoconstrictor, which severely decreases mammary
blood ﬂow, a correlate for decreased capacity for milk
production (Linzell 1974, Collier et al. 1984).
Conclusion
We have demonstrated the basic properties of the serotonergic
signaling system in dairy cows. In this process, we have
discovered profound differences between the bovine system
and that of mice and humans. Whereas human and mouse
mammary epithelial cells express predominantly the 5-HT-7,
which signals through the Gs-coupled pathway, the bovine
mammary epithelium expresses 5-HT-7, along with four
additional isoforms of 5-HT receptors (1B, 2A, 2B, and 4).
These additional receptors may signal through the Gi and
Gq/11 pathways, raising the likelihood that cows have evolved
mechanisms that have served to alter the molecular tuning of
intramammary serotonergic feedback. We have further
demonstrated that 5-HT-1B, 2A, and 7 appear to be directly
involved in milk protein gene expression in the bovine.
L L HERNANDEZ and others . Serotonin and bovine mammary gland 130
Journal of Endocrinology (2009) 203, 123–131 www.endocrinology-journals.orgOther potential mechanisms of serotonergic regulation of
mammary gland function include cell turnover, the milk
ejection reﬂex, and mammary blood ﬂow. Further studies will
be needed to delineate the exact mechanisms of serotonergic
regulation of the bovine mammary gland.
Declaration of interest
There is no conﬂict of interest that could be perceived as prejudicing the
partiality of the research reported.
Funding
This research was supported by the NRI Competitive Grant no. 2007-35206-
17898 from the USDA-CSREES.
References
AkersRM 2002 Lactation and the Mammary Gland, pp 66–87. Ames: Iowa State
Press.
Banes AKL, Shaw SM, Tawﬁk A, Patel BP, Ogbi S, Fulton D & Marrero MB
2005 Activation of the JAK/STAT pathway in vascular smooth muscle by
serotonin. American Journal of Physiology. Cell Physiology 288 805–812.
Boisgard R, Chanat E, Lavialle F, Pauloin A & Ollivier-Bousquet M 2001
Roads taken by milk protein in mammary epithelial cells. Livestock
Production Science 70 49–61.
Capuco AV & Akers RM 1999 Mammary involution in dairy animals.
Journal of Mammary Gland Biology and Neoplasia 4 137–144.
Capuco AV, Akers RM & Smith JJ 1997 Mammary growth in Holstein cows
during the dry period: quantiﬁcation of nucleic acids and histology.
Journal of Dairy Science 80 477–487.
Capuco AV, Wood DL, Baldwin R, McLeod K & Paape MJ 2001 Mammary
cell number, proliferation, and apoptosis during a bovine lactation: relation
to milk production and effect of bST. Journal of Dairy Science 84 2177–2187.
Capuco AV, Ellis SE, Hale SA, Long E, Erdman RA, Zhao X & Paape MJ
2003 Lactation persistency: insights from mammary cell proliferation
studies. Journal of Animal Science 81 18–31.
Capuco AV, Annen E, Fitzgerald AC, Ellis SE & Collier RJ 2006 Mammary
cell turnover: relevance to lactation persistency and dry period manage-
ment. In Ruminant Physiology: Digestion, Metabolism, and Impact of Nutrition
on Gene Expression, Immunology and Stress, pp 363–388. Eds K Sejrsen,
T Hvelplund & MO Nielsen. Wageningen: Wageningen Academic
Publishers.
Collier RJ, McNamara JP, Wallace CR & Dehoff MH 1984 A review of
endocrine regulation of metabolism during lactation. Journal of Animal
Science 59 498–510.
Hadjuch E, Rencurel F, Balendran A, Batty IH, Downes CP & Hundal HS
1999 Serotonin (5-hydroxytryptamine), a novel regulator of glucose
transport in rat skeletal muscle. Journal of Biological Chemistry 274
13563–13568.
Hadsell D, George J & Torres D 2007 The declining phase of lactation:
peripheral or central, programmed or pathological? Journal of Mammary
Gland Biology and Neoplasia 12 59–70.
Hernandez LL 2008 Characterization of the bovine mammary gland
serotonergic system. PhD Dissertation. University of Arizona, Tucson, AZ.
Hernandez LL, Stiening CM, Wheelock JB, Baumgard LH, Parkhurst AM &
Collier RJ 2008 Evaluation of serotonin as a feedback inhibitor of lactation
in the bovine. Journal of Dairy Science 91 1834–1844.
Horseman ND 1999 Prolactin and mammary gland development. Journal of
Mammary Gland Biology and Neoplasia 4 79–88.
Kroeze WK, Kristiansen K & Roth BL 2002 Molecular biology of serotonin
receptors-structure and function at the molecular level. Current Topics in
Medicinal Chemistry 2 507–528.
Limesand KH, Barzen KA, Quissell DO & Anderson SM 2003 Synergistic
suppression of apoptosis in salivaryacinar cells by IGF-I and EGF. Cell Death
and Differentiation 10 345–355.
Limesand SW, Jensen J, Hutton JC & Hay WW 2005 Diminshed b-cell
replication contributes to reduced b-cell mass in fetal sheep with
intrauterine growth restriction. American Journal of Physiology. Regulatory,
Integrative and Comparative Physiology 288 1297–1305.
Linzell JL 1974 Mammary blood ﬂow and methods of identifying and
measuring precursors of milk. In Lactation: a Comprehensive Treatise,
pp 143–225. Eds BL Larson & VR Smith. New York: Academic Press.
Livak KJ & Scmittgen TD 2001 Analysis of relative gene expression data using
real-time quantitative PCR and the 2KDDCt method. Methods 25 402–408.
Matsuda M, Imaoka T, Vomachka AJ, Gudelsky GA, Hou Z, Mistry M,
Bailey JP, Nieport KM, Walther DJ, Bader M et al. 2004 Serotonin regulates
mammary gland development via an autocrine-paracrine loop.
Developmental Cell 6 193–203.
McGrath MF 1987 A novel system for mammary epithelial cell culture.
Journal of Dairy Science 70 1967–1980.
Muniz M, Alonso M, Hidalgo J & Velasco A 1996 A regulatory role for
cAMP-dependent protein kinase in protein trafﬁc along the exocytic route.
Journal of Biological Chemistry 271 30935–30941.
Pai V & Horseman ND 2008 Biphasic regulation of mammary epithelial
resistance by serotonin through activation of multiple pathways. Journal of
Biological Chemistry 283 30901–30910.
Peaker M 1995 Autocrine control of milk secretion: development of the
concept. In Intracellular Signaling in the Mammary Gland, pp 193–202.
Ed. CJ Wilde. New York: Plenum Press.
Raymond JR, Mukhin Yv, Gelasco A, Turner J, Collinsworth G, Gettys TW,
Grewal JS & Garnoyskaya MN 2001 Multiplicity of mechanisms of
serotonin receptor signal transduction. Pharmacology and Therapeutics 92
179–212.
Reist M, Pfafﬂ MW, Morel C, Meylan M, Hirsbrunner G, Blum JW &
Steiner A 2003 Quantitative mRNA analysis of eight bovine 5-HTreceptor
subtypes in brain abomasums, and intestine by real-time PCR. Journal of
Receptors and Signal Transduction 23 271–287.
Rocha V, Ringo DL & Read DR 1985 Casein production during
differentiation of mammary epithelial cells in collagen gel culture.
Experimental Cell Research 159 201–210.
Rozen S & Skaletsky H 2000 Primer3 on the WWW for general users and
biologist programmers. Methods in Molecular Biology 132 365–386.
Stiening CM 2005 Genomic regulation of bovine mammary epithelial cell
growth and differentiation. PhD Dissertation. Universityof Arizona, Tucson.
Stiening CM, Hoying JB, Abdallah MB, Hoying AM, Pandey R, Greer K &
Collier RJ 2008 The effects of endocrine and mechanical stimulation on
stage I lactogenesis in bovine mammary epithelial cells. Journal of Dairy
Science 91 1053–1066.
Stull MA, Pai V, Vomachka AJ, Marshall AM, Jacob GA & Horseman ND
2007 Mammary gland homeostasis employs serotonergic regulation of
epithelial tight junctions. PNAS 104 16708–16713.
Watts SW 1998 Activation of the mitogen-activated protein kinase pathway
via the 5-HT 2A receptor. Annals of the New York Academy of Science 861
162–168.
Wilde CJ, Addey CVP, Blatchford DR, Peaker M & Casey MJ 1988 Feed-
back inhibition of milk secretion: the effect of a fraction of goat milk on
milk yield and composition. Quarterly Journal of Experimental Physiology 73
391–397.
Wilde CJ, Addey CVP, Boddy LM & Peaker M 1995 Autocrine regulation of
milk secretion by a protein in milk. Biochemical Journal 305 51–58.
Received in ﬁnal form 8 July 2009
Accepted 4 August 2009
Made available online as an Accepted Preprint
4 August 2009
Serotonin and bovine mammary gland . L L HERNANDEZ and others 131
www.endocrinology-journals.org Journal of Endocrinology (2009) 203, 123–131